# A Study to Evaluate the Effect of Testosterone on Muscle Fractional Synthetic Rate (MK-0000-064)

> **NCT00816712** · PHASE1 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 28 (actual)

## Conditions studied

- Muscle Anabolism

## Interventions

- **DRUG:** Comparator: Testosterone 300 mg, intramuscular injection
- **DRUG:** Comparator: Testosterone 100 mg, Intramuscular injection
- **DRUG:** Comparator: Placebo given by Intramuscular Injection

## Key facts

- **NCT ID:** NCT00816712
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2015-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00816712

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00816712, "A Study to Evaluate the Effect of Testosterone on Muscle Fractional Synthetic Rate (MK-0000-064)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00816712. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*